Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Millman

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Diabetes|April 24, 2025
Advances in Cell Replacement Therapies for DiabetesBernhard J Hering, Michael R Rickels, Melena D Bellin, et al.
JCI Insight|June 8, 2026
Modeling immune responses to autologous and allogeneic human stem cell-derived islet grafts in vivoCamillo Bechi Genzano, Giorgia Zanetti, Qian Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Nature Communications|December 7, 2025
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell modelPatrick A DeSouza, Matthew Ishahak, Xuan Qu, et al.
Nature Medicine|January 26, 2016
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceArturo J Vegas, Omid Veiseh, Mads Gürtler, et al.
Nature Medicine|April 7, 2016
Corrigendum: Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceArturo J Vegas, Omid Veiseh, Mads Gürtler, et al.
Nature Reviews. Endocrinology|September 3, 2024
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadAlessandro Grattoni, Gregory Korbutt, Alice A Tomei, et al.
Nature Biotechnology|May 8, 2023
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaquesXiaomeng Hu, Kathy White, Ari G Olroyd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Diabetes|April 24, 2025
Advances in Cell Replacement Therapies for DiabetesBernhard J Hering, Michael R Rickels, Melena D Bellin, et al.
JCI Insight|June 8, 2026
Modeling immune responses to autologous and allogeneic human stem cell-derived islet grafts in vivoCamillo Bechi Genzano, Giorgia Zanetti, Qian Du, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Nature Communications|December 7, 2025
INSM1 governs a neuronal progenitor state that drives glioblastoma in a human stem cell modelPatrick A DeSouza, Matthew Ishahak, Xuan Qu, et al.
Nature Medicine|January 26, 2016
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceArturo J Vegas, Omid Veiseh, Mads Gürtler, et al.
Nature Medicine|April 7, 2016
Corrigendum: Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceArturo J Vegas, Omid Veiseh, Mads Gürtler, et al.
Nature Reviews. Endocrinology|September 3, 2024
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadAlessandro Grattoni, Gregory Korbutt, Alice A Tomei, et al.
Nature Biotechnology|May 8, 2023
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaquesXiaomeng Hu, Kathy White, Ari G Olroyd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Pageof 9